BTCC / BTCC Square / tipranks /
Top Analysts Reveal: 3 Must-Buy Stocks Right Now - September 5, 2025

Top Analysts Reveal: 3 Must-Buy Stocks Right Now - September 5, 2025

Author:
tipranks
Published:
2025-09-05 11:01:22
5
2

3 Best Stocks to Buy Now, 9/5/2025, According to Top Analysts

Wall Street's sharpest minds just dropped their hottest picks—and these three names are screaming buy signals.

The Consensus Plays

Forget guessing games. When the heaviest hitters in analysis align on conviction calls, smart money listens. These aren't speculative moonshots—they're foundational plays with brutal efficiency and proven traction.

Institutional Fuel

Massive whales are already positioning. The flow doesn't lie—big capital moves where growth is guaranteed, not hoped for. It's about structural advantage, not hype.

Execution Over Promise

Each pick boasts operational discipline that would make a VC blush—actual revenue, not roadmap fantasies. They're built to scale, not just to story-tell.

Because sometimes the best trade is the one everyone already knows—but few have the nerve to actually make. Especially when traditional finance is still trying to short innovation.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

(BRZE) – Braze is a cloud-based software company that helps businesses manage customer engagement and marketing campaigns. Today, Barclays analyst Raimo Lenschow maintained a Buy rating on the stock and increased the price target to $39 from $35 per share. Interestingly, nine out of the 10 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 46.06%. 

(AVTX) – This is a biopharmaceutical company focused on developing therapies for immune and rare genetic diseases. Today, TD Cowen analyst Stacy Ku initiated a Buy rating on the stock. In the last three months, all two Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 333.07%.

(ET) – Energy Transferis a U.S. energy company that operates pipelines and storage facilities for natural gas, crude oil, and refined products. Yesterday, Barclays analyst Theresa Chen maintained a Buy rating on the stock with a price target of $25 per share. In the last three months, all six Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 27.93%.

Who Are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users